Kremedine Health Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.00 Cr
as on 16-11-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.79 Cr
as on 16-11-2024
- Satisfied Charges ₹ 11.89 Cr
as on 16-11-2024
- Revenue -14.21%
(FY 2023)
- Profit -25.95%
(FY 2023)
- Ebitda -9.76%
(FY 2023)
- Net Worth 95.24%
(FY 2023)
- Total Assets 75.06%
(FY 2023)
About Kremedine Health
The Corporate was formerly known as Konark Remedine Establishment Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹13.79 Cr. The company has closed loans amounting to ₹11.89 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sameeksha Keshav and Suyash Dubey serve as directors at the Company.
- CIN/LLPIN
U85110MP2015PTC034972
- Company No.
034972
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Nov 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kremedine Health?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suyash Dubey  | Director | 17-Nov-2015 | Current |
| Sameeksha Keshav | Director | 17-Nov-2015 | Current |
Financial Performance of Kremedine Health.
Kremedine Health Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.21% decrease. The company also saw a substantial fall in profitability, with a 25.95% decrease in profit. The company's net worth Soared by an impressive increase of 95.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kremedine Health?
In 2023, Kremedine Health had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Jul 2022 | ₹13.79 Cr | Open |
Bank Of India Creation Date: 04 Jun 2019 | ₹11.89 Cr | Satisfied |
How Many Employees Work at Kremedine Health?
Unlock and access historical data on people associated with Kremedine Health, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kremedine Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kremedine Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
